亚宝药业(600351.SH)：已累计回购20万股股份

Group 1 - The company, Yabao Pharmaceutical (600351.SH), announced that as of July 31, 2025, it has repurchased a total of 200,000 shares through centralized bidding, accounting for 0.03% of the company's total share capital [1] - The highest and lowest transaction price for the repurchased shares was 6.30 RMB per share, indicating a stable price point during the buyback [1] - The total amount paid for the share repurchase was 1.26 million RMB, excluding transaction fees, reflecting the company's commitment to returning value to shareholders [1]